Expertly delivering clinical trials, to people at home, in places all over the world
The ability to reach diverse patient populations and reduce the burden for people taking part in a clinical trial is imperative. Our Almac to Patient solution has been developed with a patient-centric approach, enabling sponsors to include patient homes as part of their decentralised trial strategy.
We understand that patient recruitment and retention is one of the biggest challenges to the success of clinical trials. Our supply chain experts, global quality, and clinical supply infrastructure, ensures effective, convenient and personalised delivery of IMP to the front doors of patients’ homes.
We achieve this via an Almac to Patient or Site to Patient solution, depending on country requirements and protocol need; providing a controlled, complete, and care-focused approach that keeps patients at the heart of the operation, every step of the journey home.